BATS BZX Real-Time Price
As of 10:38am ET
| +0.70 / +0.67%|
The 23 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 120.00, with a high estimate of 159.00 and a low estimate of 85.00. The median estimate represents a +14.95% increase from the last price of 104.39.
The current consensus among 27 polled investment analysts is to Buy stock in Gilead Sciences. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.